`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`
`NOVO NORDISK INC. and NOVO
`NORDISK A/S,
`
`Plaintiffs,
`
`v.
`
`MYLAN PHARMACEUTICALS INC.,
`
`Defendant.
`
`
`
`C.A. No. 1:22-cv-23-JPB
`
`
`
`MYLAN PHARMACEUTICALS INC.’S
`RULE 7.1 DISCLOSURE STATEMENT
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, defendant Mylan
`
`Pharmaceuticals Inc. hereby states that:
`
`1. Mylan Pharmaceuticals Inc. is a wholly-owned subsidiary of Mylan Inc. and operates
`
`as a distinct corporate entity;
`
`3. Mylan Inc. is wholly owned by Viatris Inc., a publicly-traded company, and operates
`
`as a distinct corporate entity; and
`
`4. No publicly-held company owns 10% or more of Viatris Inc.’s stock.
`
`Dated: April 8, 2022
`
`
`
`
`
`
`
`
`
`By: /s/ Brandon M. White
`Brandon M. White (WV Bar No. 14021)
`PERKINS COIE LLP
`700 13th Street NW
`Suite 800
`Washington, DC 20005
`Tel: (202) 654-6200
`bmwhite@perkinscoie.com
`
`Counsel for Mylan Pharmaceuticals Inc.
`
`
`
`Case 1:22-cv-00023-JPB Document 20 Filed 04/08/22 Page 2 of 2 PageID #: 567
`
`CERTIFICATE OF SERVICE
`
`I certify that on this 8th day of April 2022, I electronically filed the foregoing “Mylan
`
`Pharmaceuticals Inc.’s Rule 7.1 Disclosure Statement” with the Clerk of the Court using the
`
`CM/ECF system, which will send notice of the same to the following counsel of record:
`
`James F. Companion
`Sandra K. Law
`jfc@schraderlaw.com
`skl@schraderlaw.com
`Schrader Companion Duff & Law, PLLC
` 401 Main Street
`Wheeling, WV 26003
`
`Jeffrey J. Oelke
`Ryan P. Johnson
`Robert E. Counihan
`Laura T. Moran
`FENWICK & WEST LLP
`902 Broadway, Suite
`14 New York, NY 10010
`
`Counsel for Plaintiffs
`
`
`/s/ Brandon M. White
`Brandon M. White (WV Bar No. 14021)
`PERKINS COIE LLP
`700 13th Street NW
`Suite 800
`Washington, DC 20005
`Tel: (202) 654-6200
`bmwhite@perkinscoie.com
`
`Counsel for Mylan Pharmaceuticals Inc.
`
`
`
`
`
`